Painchek Ltd has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-425
6ix hasn’t read this filing yet.
Earlier from PainChek
- Compelling Clinical and Economic Results in Scottish Pilot
- Preliminary Final Report
- Strongly Supported A$7.5m Placement to Drive Int. Growth
- Final US FDA De Novo Clearance Submission Completed
- PainChek Reports Strong Quarterly Sales Growth
Later from PainChek
- PainChek FDA Cleared to Commence Sales in US$100M US Market
- PainChek Secures First US Customer Following FDA Clearance
- Response to ASX Aware Letter
- Key hire to drive Infant App in $15Bn addressable market
- Notice of Annual General Meeting/Proxy Form
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek